<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents - Buder, K - 2022 | Cochrane Library</title> <meta content="Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents - Buder, K - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009898.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents - Buder, K - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009898.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009898.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents" name="citation_title"/> <meta content="Kathrin Buder" name="citation_author"/> <meta content="University Hospital Tübingen, University Children's Hospital" name="citation_author_institution"/> <meta content="Matthias Zirngibl" name="citation_author"/> <meta content="University Hospital Tübingen, University Children's Hospital" name="citation_author_institution"/> <meta content="Sascha Bapistella" name="citation_author"/> <meta content="University Hospital Tübingen, University Children's Hospital" name="citation_author_institution"/> <meta content="Joerg J Meerpohl" name="citation_author"/> <meta content="Cochrane Germany Foundation" name="citation_author_institution"/> <meta content="Brigitte Strahm" name="citation_author"/> <meta content="University Medical School Freiburg" name="citation_author_institution"/> <meta content="Dirk Bassler" name="citation_author"/> <meta content="University Hospital Zürich" name="citation_author_institution"/> <meta content="Marcus Weitz" name="citation_author"/> <meta content="University Hospital Tübingen, University Children's Hospital" name="citation_author_institution"/> <meta content="marcus.weitz@med.uni-tuebingen.de" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD009898.pub4" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/06/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009898.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009898.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009898.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chronic Disease; *Graft vs Host Disease [therapy]; *Hematopoietic Stem Cell Transplantation [adverse effects]; Methoxsalen; *Photopheresis [adverse effects]; Steroids" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009898.pub4&amp;doi=10.1002/14651858.CD009898.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="PSzzz2OT";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009898\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009898\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ms","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009898.pub4",title:"Extracorporeal photopheresis versus alternative treatment for chronic graft\\u2010versus\\u2010host disease after haematopoietic stem cell transplantation in children and adolescents",firstPublishedDate:"Jun 9, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Childhood Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PSzzz2OT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009898.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009898.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009898.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009898.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009898.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009898.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009898.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009898.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009898.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009898.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1849 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009898.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0060"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0015"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0016"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-sec-0051"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/appendices#CD009898-sec-0064"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0004">Kathrin Buder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0005">Matthias Zirngibl</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0006">Sascha Bapistella</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0007">Joerg J Meerpohl</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0008">Brigitte Strahm</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0009">Dirk Bassler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information#CD009898-cr-0010"><i class="icon corresponding-author fa fa-envelope"></i>Marcus Weitz</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information/en#CD009898-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 June 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009898.pub4">https://doi.org/10.1002/14651858.CD009898.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009898-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009898-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009898-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009898-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009898-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009898-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009898-abs-0001" lang="en"> <section id="CD009898-sec-0001"> <h3 class="title" id="CD009898-sec-0001">Background</h3> <p>Chronic graft‐versus‐host disease (cGvHD) is a major cause of morbidity and mortality after haematopoietic stem cell transplantation, occurring in 6% to 65% of the paediatric recipients. Currently, the therapeutic mainstay for cGvHD is treatment with corticosteroids, frequently combined with other immunosuppressive agents in people with steroid‐refractory manifestations. There is no established standard treatment for steroid‐refractory cGvHD. The therapeutic options for these patients include extracorporeal photopheresis (ECP), an immunomodulatory treatment that involves ex vivo collection of mononuclear cells from peripheral blood, exposure to the photoactive agent 8‐methoxypsoralen, ultraviolet radiation and re‐infusion of the processed cell product. The mechanisms of action of ECP are not completely understood. This is the second update of a Cochrane Review first published in 2014 and first updated in 2015. </p> </section> <section id="CD009898-sec-0002"> <h3 class="title" id="CD009898-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of ECP for the management of cGvHD in children and adolescents after haematopoietic stem cell transplantation. </p> </section> <section id="CD009898-sec-0003"> <h3 class="title" id="CD009898-sec-0003">Search methods</h3> <p>We searched the Cochrane Register of Controlled Trials (CENTRAL) (2021), MEDLINE (PubMed) and Embase databases from their inception to 25 January 2021. We searched the reference lists of potentially relevant studies without any language restrictions. We searched five conference proceedings and nine clinical trial registries on 9 November 2020 and 12 November 2020, respectively. </p> </section> <section id="CD009898-sec-0004"> <h3 class="title" id="CD009898-sec-0004">Selection criteria</h3> <p>We aimed to include randomised controlled trials (RCTs) comparing ECP with or without alternative treatment versus alternative treatment alone in children and adolescents with cGvHD after haematopoietic stem cell transplantation. </p> </section> <section id="CD009898-sec-0005"> <h3 class="title" id="CD009898-sec-0005">Data collection and analysis</h3> <p>Two review authors independently performed the study selection. We resolved disagreements in the selection of trials by consultation with a third review author. </p> </section> <section id="CD009898-sec-0006"> <h3 class="title" id="CD009898-sec-0006">Main results</h3> <p>We found no studies meeting the criteria for inclusion in this 2021 review update.</p> </section> <section id="CD009898-sec-0007"> <h3 class="title" id="CD009898-sec-0007">Authors' conclusions</h3> <p>We could not evaluate the efficacy of ECP in the treatment of cGvHD in children and adolescents after haematopoietic stem cell transplantation since the second review update again found no RCTs. Current recommendations are based on retrospective or observational studies only. Thus, ideally, ECP should be applied in the context of controlled trials only. However, performing RCTs in this population will be challenging due to the limited number of eligible participants, variable disease presentation and the lack of well‐defined response criteria. International collaboration, multicentre trials and appropriate funding for such trials will be needed. If treatment decisions based on clinical data are made in favour of ECP, recipients should be carefully monitored for beneficial and harmful effects. In addition, efforts should be made to share this information with other clinicians, for example by setting up registries for children and adolescents treated with ECP. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009898-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009898-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009898-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009898-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009898-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009898-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009898-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009898-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009898-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009898-abs-0002" lang="en"> <h3>Extracorporeal photopheresis treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents </h3> <p><b>Background</b> </p> <p>Chronic graft‐versus‐host disease (cGvHD) is a common complication after haematopoietic stem cell transplantation (HSCT; transplant of blood‐forming stem cells). Immune cells (white blood cells) from the donor recognise the recipient's cells as foreign ('non‐self'). Therefore, the transplanted immune cells attack the cells of the recipient. The main affected organs are skin, liver and gut, among others. These immune reactions may cause acute inflammation (sudden swelling) followed by chronic (long‐term) changes to organs (e.g. fibrosis; scarring of the lungs). First‐line therapy usually consists of immunosuppressive drugs (which reduce the strength of the body's immune system) in the form of corticosteroids in combination with other immunosuppressive agents in refractory cases (where the disease is resistant to treatment). These drugs are supposed to suppress the immune‐mediated attack of the patient's cells. Limited effectiveness and severe side effects of these drugs have led to several alternative approaches. </p> <p>Extracorporeal photopheresis (ECP) is an immunomodulatory therapy (a treatment that makes changes to immune function) that involves collection of immune cells from peripheral blood outside the patient's body. These immune cells are exposed to a photoactive agent (a chemical that responds to exposure to light; e.g. 8‐methoxypsoralen) with subsequent ultraviolet‐A radiation and then re‐infused. We are not sure how this affects immune function. Several current clinical practice recommendations suggest consideration of ECP in children and adolescents with cGvHD. </p> <p><b>Study characteristics</b> </p> <p>We searched scientific databases for randomised controlled trials (RCTs) (clinical studies where people are randomly put into one of two or more treatment groups) that were designed to evaluate the effectiveness and safety of ECP for the management of chronic graft‐versus‐host disease in children and adolescents (less than 18 years of age) after HSCT. </p> <p><b>Results</b> </p> <p>We did not find any RCTs that analysed the efficacy of ECP for children and adolescents with cGvHD after HSCT. Current recommendations are only based on retrospective studies (where outcomes occurred to the participants before the study began) or observational studies (where investigators did not intervene, and simply observed the course of events). Ideally, ECP should only be given to children and adolescents in the context of RCTs. ECP may be considered in people with steroid‐refractory cGvHD, keeping in mind that such a treatment is not supported by high‐level evidence. If children and adolescents are given ECP, doctors should collect information about beneficial and harmful effects and set up registries for people treated with ECP. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009898-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009898-sec-0060"></div> <h3 class="title" id="CD009898-sec-0061">Implications for practice</h3> <section id="CD009898-sec-0061"> <p>The available body of evidence for the use of ECP in children and adolescents with cGvHD after HSCT is limited to case reports, case series and observational studies. The two RCTs investigating the use of ECP as first‐ and second‐line therapy enrolled only adults. Therefore, high‐quality evidence for the use of ECP in children and adolescents with cGvHD following HSCT is still of utmost importance. </p> <p>Thus, ideally, ECP should only be given to children and adults in the context of RCTs, and international efforts should be undertaken to set up such studies. </p> </section> <h3 class="title" id="CD009898-sec-0062">Implications for research</h3> <section id="CD009898-sec-0062"> <p>Well‐designed, controlled trials, preferably RCTs, should be done to generate data sufficient to support or refute the use of ECP in children with cGvHD after HSCT. </p> <p>Key issues which need to be addressed in trials include:</p> <p> <ul id="CD009898-list-0009"> <li> <p>adequately powered studies;</p> </li> <li> <p>use of common and validated diagnosis and scoring systems for cGvHD grading according to the revised 2014 NIH consensus criteria (<a href="./references#CD009898-bbs2-0058" title="JagasiaMH , GreinixHT , AroraM , WilliamsKM , WolffD , CowenEW , et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2015;21(3):389-401.">Jagasia 2015</a>; <a href="./references#CD009898-bbs2-0095" title="SchoemansHM , LeeSJ , FerraraJL , WolffD , LevineJE , SchultzKR , et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology &amp; guidance for graft-versus-host disease assessment. Bone Marrow Transplantation2018;53(11):1401-15.">Schoemans 2018</a>) </p> </li> <li> <p>stratification of participants to predefined subgroups;</p> </li> <li> <p>standardisation of ECP regimens (e.g. timing, scheduling, dosing);</p> </li> <li> <p>precise reporting of additional and supportive therapies (including standardisation of steroid tapering); </p> </li> <li> <p>use of exact definitions of comparable outcome measures (e.g. treatment response according to the 2014 NIH consensus criteria (<a href="./references#CD009898-bbs2-0068" title="LeeSJ , WolffD , KitkoC , KorethJ , InamotoY , JagasiaM , et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation2015;21(6):984-99.">Lee 2015</a>), (long‐term) survival; relapse rate in case of malignancy); </p> </li> <li> <p>incorporation of other essential and feasible outcome measures (e.g. safety, quality of life, costs of intervention); </p> </li> <li> <p>adequate follow‐up periods.</p> </li> </ul> </p> <p>If treatment decisions based on clinical grounds are made in favour of ECP, children and adolescents should be carefully monitored for beneficial and harmful effects. Efforts should be made to share this information with other clinicians, for example by setting up registries for children and adolescents treated with ECP. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009898-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009898-sec-0008"></div> <div class="table" id="CD009898-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Extracorporeal photopheresis (ECP) compared with alternative treatment for chronic graft‐versus‐host disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation </p> <p><b>Settings:</b> paediatric hospitals worldwide </p> <p><b>Intervention:</b> ECP alone or in combination with standard treatment </p> <p><b>Comparison:</b> alternative treatment alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk without ECP</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with ECP</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Response</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure‐free survival</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cost of intervention per month</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>*The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% confidence interval).<br/><b>CI:</b> Confidence interval; <b>RCT</b>s: randomised controlled trials. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009898-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009898-sec-0009"></div> <section id="CD009898-sec-0010"> <h3 class="title" id="CD009898-sec-0010">Description of the condition</h3> <p>Haematopoietic stem cell transplantation (HSCT) is a curative treatment option for children with haematological malignancies, haemoglobinopathies, immune deficiencies, inborn errors of metabolism and autoimmune diseases (<a href="./references#CD009898-bbs2-0023" title="DiaconescuR , StorbR . Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care. Journal of Cancer Research and Clinical Oncology2005;131(1):1-13.">Diaconescu 2005</a>; <a href="./references#CD009898-bbs2-0037" title="GazievJ , LucarelliG . Hematopoietic stem cell transplantation for thalassemia. Current Stem Cell Research and Therapy2010;6(2):162-9.">Gaziev 2010</a>; <a href="./references#CD009898-bbs2-0043" title="GrecoR , LabopinM , BadoglioM , VeysP , Furtado SilvaJM , AbinunM , et al. Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT ADWP, IEWP, and PDWP working parties. Frontiers in Immunology2019;10:1570.">Greco 2019</a>; <a href="./references#CD009898-bbs2-0063" title="Kennedy-NasserAA , LeungKS , MahajanA , WeissHL , ArceJA , GottschalkS , et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biology of Blood and Marrow Transplantation2006;12(12):1277-84.">Kennedy‐Nasser 2006</a>; <a href="./references#CD009898-bbs2-0088" title="PetersC , StewardCG . Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplantation2003;31(4):229-39.">Peters 2003</a>; <a href="./references#CD009898-bbs2-0090" title="RappeportJM , O'ReillyRJ , KapoorN , ParkmanR . Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Hematology/Oncology Clinics of North America2011;25(1):17-30.">Rappeport 2011</a>; <a href="./references#CD009898-bbs2-0114" title="WaltersMC , StorbR , PatienceM , LeisenringW , TaylorT , SandersJE , et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood2000;95(6):1918-24.">Walters 2000</a>; <a href="./references#CD009898-bbs2-0115" title="WaltersMC . Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program2005;2005:66-73.">Walters 2005</a>). Chronic graft‐versus‐host disease (cGvHD) is considered one of the major complications following HSCT, limiting its wider application (<a href="./references#CD009898-bbs2-0011" title="BillinghamRE . The biology of graft-versus-host reactions. Harvey Lectures1966;62:21-78.">Billingham 1966</a>; <a href="./references#CD009898-bbs2-0028" title="Ferrara JLM Antin J. The pathophysiology of graft-vs-host disease. In: BlumeKG , FormanSJ , AppelbaumFR , editors(s). Thomas' Hematopoietic Cell Transplantation. 3rd edition. Malden, MA: Blackwell Science, 2004:353-68.">Ferrara 2004</a>; <a href="./references#CD009898-bbs2-0107" title="SullivanK . Graft-versus-host disease. In: BlumeKG , FormanSJ , AppelbaumFR , editors(s). Thomas Hematopoietic Cell Transplantation. 3rd edition. Malden, MA: Blackwell Science, 2004:633-64.">Sullivan 2004</a>). cGvHD was traditionally defined by manifestation after 100 days following HSCT (<a href="./references#CD009898-bbs2-0038" title="GilmanAL , ChanKW , MogulA , MorrisC , GoldmanFD , BoyerM , et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2000;6(3A):327-34.">Gilman 2000</a>). Several advances in the practice of HSCT (including different haematopoietic stem cell sources, intensity of conditioning regimen, immunosuppression and donor lymphocyte infusions) resulted in a more time‐variable presentation of cGvHD (<a href="./references#CD009898-bbs2-0015" title="BuninNJ , DaviesSM , AplencR , CamittaBM , DeSantesKB , GoyalRK , et al. Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. Journal of Clinical Oncology2008;26(26):4326-32.">Bunin 2008</a>; <a href="./references#CD009898-bbs2-0026" title="EapenM , HorowitzMM , KleinJP , ChamplinRE , Loberiza FR Jr, RingdénO , et al, the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents. Journal of Clinical Oncology2004;22(24):4872-80.">Eapen 2004</a>). Therefore, cGvHD is described according to its pattern of presentation: following HSCT as a progression from acute graft‐versus‐host disease (aGvHD) (progressive form); as a recurrence after a disease‐free interval (quiescent form); and without a history of aGvHD (de novo form) (<a href="./references#CD009898-bbs2-0099" title="ShulmanHM , SullivanKM . Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. Concepts in Immunopathology1988;6:141-65.">Shulman 1988</a>). The US National Institutes of Health (NIH) developed a diagnosis and scoring system defining cGvHD based on specific clinical signs and histopathology rather than time of onset after HSCT (<a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>; <a href="./references#CD009898-bbs2-0057" title="JagasiaMH , SavaniBN , StricklinG , EngelhardtB , KassimA , DixonS , et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biology of Blood and Marrow Transplantation2009;15(10):1288-95. [NCT01380535]">Jagasia 2009</a>). The NIH global severity score uses a numerical scoring system for individual organs to calculate a summary scale according to the number and severity of organs involved. Consequently, cGvHD is categorised as mild, moderate or severe (<a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>). This provides a more clinically informative and discriminating severity measure for use in clinical trials, and is an indicator for the necessity of systemic immunosuppressive treatment (<a href="./references#CD009898-bbs2-0005" title="AraiS , JagasiaM , StorerB , ChaiX , PidalaJ , CutlerC , et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood2010;118(15):4242-9.">Arai 2010</a>). The NIH criteria for diagnosis of cGvHD were refined in 2014 and are still recommended to be used in clinical trials (<a href="./references#CD009898-bbs2-0058" title="JagasiaMH , GreinixHT , AroraM , WilliamsKM , WolffD , CowenEW , et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2015;21(3):389-401.">Jagasia 2015</a>; <a href="./references#CD009898-bbs2-0095" title="SchoemansHM , LeeSJ , FerraraJL , WolffD , LevineJE , SchultzKR , et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology &amp; guidance for graft-versus-host disease assessment. Bone Marrow Transplantation2018;53(11):1401-15.">Schoemans 2018</a>). </p> <p>The incidence of cGvHD in the paediatric population varies between 6% and 65%, depending on the transplant procedure and disease‐specific variables (<a href="./references#CD009898-bbs2-0007" title="BairdK , CookeK , SchultzKR . Chronic graft-versus-host disease (GVHD) in children. Pediatric Clinics of North America2010;57(1):297-322.">Baird 2010</a>; <a href="./references#CD009898-bbs2-0076" title="MeiselR , LawsHJ , BalzerS , BernbeckB , KrammC , SchonbergerS , et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biology of Blood and Marrow Transplantation2007;13(11):1338-45.">Meisel 2007</a>; <a href="./references#CD009898-bbs2-0092" title="RochaV , Wagner JE Jr, SobocinskiKA , KleinJP , ZhangMJ , HorowitzMM , et al, Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. New England Journal of Medicine2000;342(25):1846-54.">Rocha 2000</a>; <a href="./references#CD009898-bbs2-0121" title="ZeccaM , PreteA , RondelliR , LaninoE , BalduzziA , MessinaC , et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood2002;100(4):1192-200.">Zecca 2002</a>). Well‐known risk factors for developing cGvHD are precedent aGvHD, stem cell donor, the preparative regimen, prophylactic procedures and the underlying disease (<a href="./references#CD009898-bbs2-0032" title="FlowersME , InamotoY , CarpenterPA , LeeSJ , PetersdorfEW , PereiraSE , et al. Comparative analysis of risk factors for acute and for chronic graft-versus-host-disease according to National Institute of Health consensus criteria. Blood2011;117(11):3214-9.">Flowers 2011</a>; <a href="./references#CD009898-bbs2-0092" title="RochaV , Wagner JE Jr, SobocinskiKA , KleinJP , ZhangMJ , HorowitzMM , et al, Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. New England Journal of Medicine2000;342(25):1846-54.">Rocha 2000</a>; <a href="./references#CD009898-bbs2-0121" title="ZeccaM , PreteA , RondelliR , LaninoE , BalduzziA , MessinaC , et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood2002;100(4):1192-200.">Zecca 2002</a>; <a href="./references#CD009898-bbs2-0122" title="ZeiserR , BlazarBR . Pathophysiology of chronic graft-versus-host disease and therapeutic targets. New England Journal of Medicine2017;377(26):2565-79.">Zeiser 2017</a>). The exact pathogenesis of cGvHD remains unclear. Several studies have demonstrated the role of T cells in the development of cGvHD (<a href="./references#CD009898-bbs2-0021" title="De BuegerM , BakkerA , BontkesH , vanRoodJJ , GoulmyE . High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. Bone Marrow Transplantation1993;11(5):363-8.">De Bueger 1993</a>; <a href="./references#CD009898-bbs2-0052" title="HigmanMA , VogelsangGB . Chronic graft versus host disease. British Journal of Haematology2004;125(4):435-54.">Higman 2004</a>; <a href="./references#CD009898-bbs2-0082" title="MutisT , GillespieG , SchramaE , FalkenburgJH , MossP , GoulmyE . Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nature Medicine1999;5(7):839-42.">Mutis 1999</a>). Increased levels of non‐specific antibodies in people with cGvHD and response to B‐cell‐depleting antibodies suggest that B cells also play a role (<a href="./references#CD009898-bbs2-0004" title="AllanSE , CromeSQ , CrellinNK , PasseriniL , SteinerTS , BacchettaR , et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. International Immunology2007;19(4):345-54.">Allan 2007</a>; <a href="./references#CD009898-bbs2-0123" title="ZhangC , TodorovI , ZhangZ , LiuY , KandeelF , FormanS , et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood2006;107(7):2993-3001.">Zhang 2006</a>). Moreover, a co‐ordinated T‐cell B‐cell interaction to minor histocompatibility alloantigens seems to account for the manifestation of cGvHD (<a href="./references#CD009898-bbs2-0079" title="MiklosDB , KimHT , MillerKH , GuoL , ZornE , LeeSJ , et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood2005;105(7):2973-8.">Miklos 2005</a>). Soluble inflammation‐associated factors are also involved in the pathogenesis of cGvHD (<a href="./references#CD009898-bbs2-0036" title="FujiiH , CuvelierG , SheK , AslanianS , ShimizuH , KariminiaA , et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood2008;111(6):3276-85.">Fujii 2008</a>; <a href="./references#CD009898-bbs2-0070" title="LinMT , StorerB , MartinPJ , TsengLH , GooleyT , ChenPJ , et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. New England Journal of Medicine2003;349(23):2201-10.">Lin 2003</a>). Other pathogenetic suggestions include a defective negative selection of autoreactive T cells due to thymic damage, aberrant production of transforming growth factor‐beta and activation of the platelet‐derived growth factor receptor, as well as deficiency of CD8+ cells (<a href="./references#CD009898-bbs2-0074" title="MartinPJ . Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio Journal of Medicine2008;57(4):177-83.">Martin 2008</a>; <a href="./references#CD009898-bbs2-0109" title="ToubaiT , SunY , ReddyP . GVHD pathophysiology: is acute different from chronic?Best Practice and Research. Clinical Haematology2008;21(2):101-17.">Toubai 2008</a>; <a href="./references#CD009898-bbs2-0122" title="ZeiserR , BlazarBR . Pathophysiology of chronic graft-versus-host disease and therapeutic targets. New England Journal of Medicine2017;377(26):2565-79.">Zeiser 2017</a>). Clinical manifestations of cGvHD are separated into rather inflammatory, acute type features (erythematous rash, mucositis, diarrhoea, transaminitis and pulmonary infiltrates) as opposed to more fibrotic, chronic characteristics (sclerotic and lichen planus‐like skin changes, fasciitis, sicca syndrome, oesophageal strictures and bronchiolitis obliterans) (<a href="./references#CD009898-bbs2-0031" title="FlowersME , ParkerPM , JohnstonLJ , MatosAV , StorerB , BensingerWI , et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood2002;100(2):415-9.">Flowers 2002</a>; <a href="./references#CD009898-bbs2-0052" title="HigmanMA , VogelsangGB . Chronic graft versus host disease. British Journal of Haematology2004;125(4):435-54.">Higman 2004</a>). The most commonly affected organs, isolated or in combination, are the skin and oral cavity, with over 70% involvement for both, followed by eyes, liver, lungs, gastrointestinal tract and musculoskeletal system (<a href="./references#CD009898-bbs2-0006" title="AtkinsonK , HorowitzMM , GaleRP , Van BekkumDW , GluckmanE , GoodRA , et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood1990;75(12):2459-64.">Atkinson 1990</a>; <a href="./references#CD009898-bbs2-0009" title="BeredjiklianPK , DrummondDS , DormansJP , DavidsonRS , BrockGT , AugustC . Orthopaedic manifestations of chronic graft-versus-host disease. Journal of Pediatric Orthopedics1998;18(5):572-5.">Beredjiklian 1998</a>; <a href="./references#CD009898-bbs2-0017" title="ChosidowO , BagotM , VernantJP , RoujeauJC , CordonnierC , KuentzM , et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. Journal of the American Academy of Dermatology1992;26(1):49-55.">Chosidow 1992</a>; <a href="./references#CD009898-bbs2-0018" title="CookeK , YanikG . Lung injury following hematopoietic cell transplantation. In: AppelbaumF , FormanS , NegrinR , editors(s). Thomas' Hematopoietic Cell Transplantation. 4th edition. Oxford: Wiley-Blackwell, 2009:1456-72.">Cooke 2009</a>; <a href="./references#CD009898-bbs2-0025" title="DudekAZ , MahasethH , DeForTE , WeisdorfDJ . Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biology of Blood and Marrow Transplantation2003;9(10):657-66.">Dudek 2003</a>; <a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>; <a href="./references#CD009898-bbs2-0060" title="JaninA , SocieG , DevergieA , AractingiS , EsperouH , VerolaO , et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Annals of Internal Medicine1994;120(12):993-8.">Janin 1994</a>; <a href="./references#CD009898-bbs2-0067" title="LeeSJ , VogelsangG , FlowersME . Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2003;9(4):215-33.">Lee 2003</a>; <a href="./references#CD009898-bbs2-0077" title="Melin-AldanaH , ThormannK , DuerstR , KletzelM , JacobsohnDA . Hepatitic pattern of graft versus host disease in children. Pediatric Blood and Cancer2007;49(5):727-30.">Melin‐Aldana 2007</a>; <a href="./references#CD009898-bbs2-0086" title="PavleticSZ , CarterSL , KernanNA , Henslee-DowneyJ , MendizabalAM , PapadopoulosE , et al. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood2005;106(9):3308-13.">Pavletic 2005</a>; <a href="./references#CD009898-bbs2-0104" title="SullivanKM , ShulmanHM , StorbR , WeidenPL , WitherspoonRP , McDonaldGB , et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood1981;57(2):267-76.">Sullivan 1981</a>; <a href="./references#CD009898-bbs2-0110" title="TreisterNS , WooSB , O'HolleranEW , LehmannLE , ParsonsSK , GuinanEC . Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation2005;11(9):721-31.">Treister 2005</a>). While aGvHD mainly affects the skin, liver and gastrointestinal tract, cGvHD may involve every organ system (<a href="./references#CD009898-bbs2-0007" title="BairdK , CookeK , SchultzKR . Chronic graft-versus-host disease (GVHD) in children. Pediatric Clinics of North America2010;57(1):297-322.">Baird 2010</a>; <a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>; <a href="./references#CD009898-bbs2-0122" title="ZeiserR , BlazarBR . Pathophysiology of chronic graft-versus-host disease and therapeutic targets. New England Journal of Medicine2017;377(26):2565-79.">Zeiser 2017</a>). </p> <p>Both cGvHD and treatment of cGvHD lead to significant morbidity and mortality in children. The leading cause of death in affected children is life‐threatening infection due to long‐term immunosuppressive treatment (<a href="./references#CD009898-bbs2-0007" title="BairdK , CookeK , SchultzKR . Chronic graft-versus-host disease (GVHD) in children. Pediatric Clinics of North America2010;57(1):297-322.">Baird 2010</a>; <a href="./references#CD009898-bbs2-0053" title="InagakiJ , MoritakeH , NishikawaT , HyakunaN , OkadaM , SuenobuS , et al. Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health Consensus Criteria after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation2015;21(11):1973-80.">Inagaki 2015</a>; <a href="./references#CD009898-bbs2-0112" title="VogelsangGB . How I treat chronic graft-versus-host disease. Blood2001;97(5):1196-201.">Vogelsang 2001</a>). Only a few studies have evaluated the long‐term outcome in the paediatric population with cGvHD (<a href="./references#CD009898-bbs2-0053" title="InagakiJ , MoritakeH , NishikawaT , HyakunaN , OkadaM , SuenobuS , et al. Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health Consensus Criteria after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation2015;21(11):1973-80.">Inagaki 2015</a>; <a href="./references#CD009898-bbs2-0056" title="JacobsohnDA , AroraM , KleinJP , HassebroekA , FlowersME , CutlerCS , et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood2011;118(16):4472-9.">Jacobsohn 2011</a>; <a href="./references#CD009898-bbs2-0121" title="ZeccaM , PreteA , RondelliR , LaninoE , BalduzziA , MessinaC , et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood2002;100(4):1192-200.">Zecca 2002</a>). Among these, a larger study involving children and adolescents with cGvHD reported a cumulative non‐relapse mortality of 15.8%, 18.1% and 24.4% at 5, 10 and 15 years following diagnosis of cGvHD. In the presence of severe cGvHD, the 10‐year cumulative non‐relapse mortality was significantly higher (35%) compared to mild (3.8%) or moderate cGvHD (4.4%) (<a href="./references#CD009898-bbs2-0053" title="InagakiJ , MoritakeH , NishikawaT , HyakunaN , OkadaM , SuenobuS , et al. Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health Consensus Criteria after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation2015;21(11):1973-80.">Inagaki 2015</a>). In order to control cGvHD, more than 50% of children and adolescents require systemic immunosuppressive therapy for more than one year (<a href="./references#CD009898-bbs2-0056" title="JacobsohnDA , AroraM , KleinJP , HassebroekA , FlowersME , CutlerCS , et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood2011;118(16):4472-9.">Jacobsohn 2011</a>). </p> <section id="CD009898-sec-0011"> <h4 class="title">Management options</h4> <p>Since aGvHD also has a significant impact on the pathogenesis of cGvHD, prophylaxis to prevent graft‐versus‐host disease (GvHD) plays a major role (<a href="./references#CD009898-bbs2-0089" title="RamR , Gafter-GviliA , YeshurunM , PaulM , RaananiP , ShpilbergO . Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplantation2009;43(8):643-53.">Ram 2009</a>). Prevention is based on T‐cell inhibition including the following strategies: inhibition of T‐cell activation and function (calcineurin inhibitor), inhibition of T‐cell proliferation (methotrexate, mycophenolate mofetil) and elimination of T cells (alemtuzumab, anti‐thymoglobulin) (<a href="./references#CD009898-bbs2-0098" title="ShahAJ , KapoorN , CrooksGM , WeinbergKI , AzimHA , KillenR , et al. The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biology of Blood and Marrow Transplantation2007;13(5):584-93.">Shah 2007</a>; <a href="./references#CD009898-bbs2-0103" title="StorbR , DeegHJ , FarewellV , DoneyK , AppelbaumF , BeattyP , et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood1986;68(1):119-25.">Storb 1986</a>). The majority of children undergoing HSCT receive GvHD prophylaxis, starting before transplantation and typically continuing for up to six months after transplantation (<a href="./references#CD009898-bbs2-0008" title="BarrettAJ , Le BlancK . Prophylaxis of acute GVHD: manipulate the graft or the environment?Best Practice and Research. Clinical Haematology2008;21(2):165-76.">Barrett 2008</a>). </p> <p>The clinical management of people with cGvHD is complicated due to the variability of disease manifestation, clinical course, infectious complications and treatment‐related toxicity (<a href="./references#CD009898-bbs2-0031" title="FlowersME , ParkerPM , JohnstonLJ , MatosAV , StorerB , BensingerWI , et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood2002;100(2):415-9.">Flowers 2002</a>). Therefore, treatment of cGvHD in children is highly variable, and, due to lack of paediatric studies, mostly based on the experience in adults. In people with mild cGvHD and high‐risk malignancies where a graft‐versus‐leukaemia effect gains importance, topical therapy should be considered (<a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>). Drug therapy for mild cGvHD mostly includes locally applied immunosuppressive agents (steroids and calcineurin inhibitors) for the affected organ (skin, eyes, oral cavity and lungs) (<a href="./references#CD009898-bbs2-0055" title="JacobsohnDA . Optimal management of chronic graft-versus-host disease in children. British Journal of Haematology2010;150(3):278-92.">Jacobsohn 2010</a>). In contrast, moderate‐to‐severe cGvHD is mostly treated with systemic steroids (<a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>; <a href="./references#CD009898-bbs2-0093" title="SalmasianH , RohanizadeganM , BanihosseiniS , Rahimi DarabadR , Rabbani-AnariM , ShakibaA , et al. Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD005565. [DOI: 10.1002/14651858.CD005565.pub2]">Salmasian 2010</a>). Prednisone is usually tapered (alternate day) for the next two to three months (<a href="./references#CD009898-bbs2-0105" title="SullivanKM , WitherspoonRP , StorbR , DeegHJ , DahlbergS , SandersJE , et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood1988;72(2):555-61.">Sullivan 1988a</a>). Some reports suggest better response rates and fewer corticosteroid complications when adding a calcineurin inhibitor (ciclosporin, tacrolimus) to systemic steroids (<a href="./references#CD009898-bbs2-0065" title="KocS , LeisenringW , FlowersME , AnasettiC , DeegHJ , NashRA , et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood2002;100(1):48-51.">Koc 2002</a>; <a href="./references#CD009898-bbs2-0106" title="SullivanKM , WitherspoonRP , StorbR , WeidenP , FlournoyN , DahlbergS , et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood1988;72(2):546-54.">Sullivan 1988b</a>; <a href="./references#CD009898-bbs2-0112" title="VogelsangGB . How I treat chronic graft-versus-host disease. Blood2001;97(5):1196-201.">Vogelsang 2001</a>). Regarding the effect of corticosteroids on the growth and development of children and the mean duration of therapy of three years for people with cGvHD, the management of a daily calcineurin inhibitor with alternate day prednisone is considered standard for the treatment of cGvHD (<a href="./references#CD009898-bbs2-0065" title="KocS , LeisenringW , FlowersME , AnasettiC , DeegHJ , NashRA , et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood2002;100(1):48-51.">Koc 2002</a>; <a href="./references#CD009898-bbs2-0105" title="SullivanKM , WitherspoonRP , StorbR , DeegHJ , DahlbergS , SandersJE , et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood1988;72(2):555-61.">Sullivan 1988a</a>). This therapeutic regimen yielded an objective response in more than 50% of people (<a href="./references#CD009898-bbs2-0105" title="SullivanKM , WitherspoonRP , StorbR , DeegHJ , DahlbergS , SandersJE , et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood1988;72(2):555-61.">Sullivan 1988a</a>; <a href="./references#CD009898-bbs2-0106" title="SullivanKM , WitherspoonRP , StorbR , WeidenP , FlournoyN , DahlbergS , et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood1988;72(2):546-54.">Sullivan 1988b</a>). </p> <p>In cases where there is no response to therapy within four weeks, second‐line treatment is mostly considered (<a href="./references#CD009898-bbs2-0055" title="JacobsohnDA . Optimal management of chronic graft-versus-host disease in children. British Journal of Haematology2010;150(3):278-92.">Jacobsohn 2010</a>). There are various salvage therapies, including general immunosuppressants (mycophenolate mofetil, azathioprine, methotrexate, sirolimus, thalidomide, pentostatin and hydroxychloroquine), monoclonal antibodies (rituximab, tocilizumab), kinase inhibitors (ibratunib, imatinib, ruxolitinib) and proteasome inhibitors (bortezomib) (<a href="./references#CD009898-bbs2-0003" title="AkpekG , LeeSM , AndersV , VogelsangGB . A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2001;7(9):495-502.">Akpek 2001</a>; <a href="./references#CD009898-bbs2-0013" title="Bolanos-MeadeJ , VogelsangGB . Chronic graft-versus-host disease. Current Pharmaceutical Design2008;14(20):1974-86.">Bolanos‐Meade 2008</a>; <a href="./references#CD009898-bbs2-0016" title="BuscaA , SarogliaEM , LaninoE , ManfrediniL , UderzoC , NicoliniB , et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplantation2000;25(10):1067-71.">Busca 2000</a>; <a href="./references#CD009898-bbs2-0019" title="CutlerC , MiklosD , KimHT , TreisterN , WooSB , BienfangD , et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood2006;108(2):756-62.">Cutler 2006</a>; <a href="./references#CD009898-bbs2-0024" title="DignanFL , AmroliaP , ClarkA , CornishJ , JacksonG , MahendraP , et al. Diagnosis and management of chronic graft-versus-host disease. British Journal of Haematology2012;158(1):46-61.">Dignan 2012</a>; <a href="./references#CD009898-bbs2-0035" title="FraserCJ , Scott BakerK . The management and outcome of chronic graft-versus-host disease. British Journal of Haematology2007;138(2):131-45.">Fraser 2007</a>; <a href="./references#CD009898-bbs2-0039" title="GilmanAL , SerodyJ . Diagnosis and treatment of chronic graft-versus-host disease. Seminars in Hematology2006;43(1):70-80.">Gilman 2006</a>; <a href="./references#CD009898-bbs2-0041" title="GoldbergJD , JacobsohnDA , MargolisJ , ChenAR , AndersV , PhelpsM , et al. Pentostatin for the treatment of chronic graft-versus-host disease in children. Journal of Pediatric Hematology/Oncology2003;25(7):584-8.">Goldberg 2003</a>; <a href="./references#CD009898-bbs2-0054" title="JacobsohnDA , GilmanAL , RademakerA , BrowningB , GrimleyM , LehmannL , et al, Pediatric Blood and Marrow Transplant Consortium study. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children. Blood2009;114(20):4354-60.">Jacobsohn 2009</a>; <a href="./references#CD009898-bbs2-0061" title="JohnstonLJ , BrownJ , ShizuruJA , Stockerl-GoldsteinKE , StuartMJ , BlumeKG , et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2005;11(1):47-55.">Johnston 2005</a>; <a href="./references#CD009898-bbs2-0071" title="LopezF , ParkerP , NademaneeA , RodriguezR , Al-KadhimiZ , BhatiaR , et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2005;11(4):307-13.">Lopez 2005</a>; <a href="./references#CD009898-bbs2-0075" title="MartinPJ , StorerBE , RowleySD , FlowersME , LeeSJ , CarpenterPA , et al. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood2009;113(21):5074-82.">Martin 2009</a>; <a href="./references#CD009898-bbs2-0081" title="MookerjeeB , AltomonteV , VogelsangG . Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation1999;24(5):517-20.">Mookerjee 1999</a>; <a href="./references#CD009898-bbs2-0111" title="VogelsangGB , FarmerER , HessAD , AltamonteV , BeschornerWE , JabsDA , et al. Thalidomide for the treatment of chronic graft-versus-host disease. New England Journal of Medicine1992;326(16):1055-8.">Vogelsang 1992</a>; <a href="./references#CD009898-bbs2-0122" title="ZeiserR , BlazarBR . Pathophysiology of chronic graft-versus-host disease and therapeutic targets. New England Journal of Medicine2017;377(26):2565-79.">Zeiser 2017</a>). </p> </section> </section> <section id="CD009898-sec-0012"> <h3 class="title" id="CD009898-sec-0012">Description of the intervention</h3> <p>Extracorporeal photopheresis (ECP), an immunomodulatory therapy, may play a role in the treatment of cGvHD. During ECP, peripheral mononuclear cells are collected ex vivo by leukapheresis, incubated with the photoactive and photosensitising drug 8‐methoxypsoralen (8‐MOP), exposed to ultraviolet‐A (UV‐A) light and then re‐infused into the patient without any adverse effects to other organs (<a href="./references#CD009898-bbs2-0010" title="BetheaD , FullmerB , SyedS , SeltzerG , TianoJ , RischkoC , et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. Journal of Dermatological Science1999;19(2):78-88.">Bethea 1999</a>; <a href="./references#CD009898-bbs2-0040" title="GirardiM , SchechnerJ , GlusacE , BergerC , EdelsonR . Transimmunization and the evolution of extracorporeal photochemotherapy. Transfusion and Apheresis Science2002;26(3):181-90.">Girardi 2002</a>; <a href="./references#CD009898-bbs2-0046" title="HealdP , PerezM , McKiernanG , ChristiensenI , EdelsonR . Extracorporeal photochemotherapy: indications, methodology, safety aspects, side effects and long-term results. Photo-dermatology1989;6(4):171-6.">Heald 1989</a>). Psoralen occurs naturally in the seeds of the furocoumarin family of plants and its exposure to UV‐A light (wavelength 200 to 350 nm) facilitates the intercalation of psoralen with deoxyribonucleic acid (DNA), leading to the formation of both monofunctional and bifunctional adducts, which results in programmed cell death (apoptosis) of the majority of cells (<a href="./references#CD009898-bbs2-0120" title="YooEK , RookAH , ElenitsasR , GasparroFP , VowelsBR . Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. Journal of Investigative Dermatology1996;107(2):235-42.">Yoo 1996</a>). Initially, the patients received psoralen orally prior to the leukapheresis (<a href="./references#CD009898-bbs2-0010" title="BetheaD , FullmerB , SyedS , SeltzerG , TianoJ , RischkoC , et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. Journal of Dermatological Science1999;19(2):78-88.">Bethea 1999</a>). However, oral application results in an inconstant absorption of the drug and considerable gastrointestinal adverse effects (<a href="./references#CD009898-bbs2-0014" title="BricklR , SchmidJ , KossFW . Clinical pharmacology of oral psoralen drugs. Photo-dermatology1984;1(4):174-86.">Brickl 1984</a>). The now generally used ex vivo method, with the incubation of the collected cells in a bag, significantly reduces the exposure of the patient to 8‐MOP (<a href="./references#CD009898-bbs2-0096" title="SchoonemanF . Extracorporeal photopheresis technical aspects. Transfusion and Apheresis Science2003;28(1):51-61.">Schooneman 2003</a>). </p> <p>ECP has been successfully applied in the treatment of cutaneous T‐cell lymphoma since the 1980s (<a href="./references#CD009898-bbs2-0027" title="EdelsonR , BergerC , GasparroF , JegasothyB , HealdP , WintroubB , et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. New England Journal of Medicine1987;316(6):297-303.">Edelson 1987</a>). Following this observation, the method has been implemented for a wider spectrum of immunologically mediated diseases such as systemic scleroderma, autoimmune disorders, solid organ rejection, aGvHD and cGvHD (<a href="./references#CD009898-bbs2-0108" title="SzodorayP , PappG , NakkenB , HarangiM , ZeherM . The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation. Autoimmunity Reviews2010;9(6):459-64.">Szodoray 2010</a>). In the paediatric setting, many authors report a response rate of 33% to 93% to ECP as second‐line treatment in steroid‐resistant cGvHD (<a href="./references#CD009898-bbs2-0034" title="FossFM , DiVenutiGM , ChinK , SpragueK , GrodmanH , KleinA , et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplantation2005;35(12):1187-93.">Foss 2005</a>; <a href="./references#CD009898-bbs2-0078" title="MessinaC , LocatelliF , LaninoE , UderzoC , ZacchelloG , CesaroS , et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. British Journal of Haematology2003;122(1):118-27.">Messina 2003</a>; <a href="./references#CD009898-bbs2-0100" title="SmithEP , SniecinskiI , DagisAC , ParkerPM , SnyderDS , SteinAS , et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biology of Blood and Marrow Transplantation1998;4(1):27-37.">Smith 1998</a>; <a href="./references#CD009898-bbs2-0101" title="SniecinskiI . Extracorporeal photochemotherapy: a scientific overview. Transfusion Science1994;15(4):429-37.">Sniecinski 1994</a>). Overall, the response rates differ with regard to the organs affected by cGvHD, with most favourable results in skin (74%), oral mucosal (72%) and liver (68%) involvement (<a href="./references#CD009898-bbs2-0073" title="MalikMI , LitzowM , HoganW , PatnaikM , MuradMH , ProkopLJ , et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis. Blood Research2014;49(2):100-6.">Malik 2014</a>). People with steroid‐refractory cGvHD who respond to ECP have a higher five‐year survival rate compared with non‐responders (96% with responders versus 85% with non‐responders) (<a href="./references#CD009898-bbs2-0087" title="PerottiC , Del FanteC , TinelliC , ViarengoG , ScudellerL , ZeccaM , et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion2010;50(6):1359-69.">Perotti 2010</a>). Adverse reactions are uncommon (less than 0.003%), transient and mild (nausea, hypotension, dizziness, cytopenia, skin infection at site of venous access and abnormal clotting to heparin) (<a href="./references#CD009898-bbs2-0062" title="KanoldJ , PaillardC , HalleP , D'IncanM , BordigoniP , DeméocqF . Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfusion and Apheresis Science2003;28(1):71-80.">Kanold 2003</a>). Moreover, ECP is not associated with increased risk of systemic infections and relapse of malignant disease (<a href="./references#CD009898-bbs2-0020" title="Dall'AmicoR , MessinaC . Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Therapeutic Apheresis2002;6(4):296-304.">Dall'Amico 2002</a>; <a href="./references#CD009898-bbs2-0045" title="HacksteinH , MisterekJ , NockherA , ReiterA , BeinG , WoessmannW . Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Transfusion2009;49(11):2366-73.">Hackstein 2009</a>; <a href="./references#CD009898-bbs2-0094" title="ScarisbrickJJ , TaylorP , HoltickU , MakarY , DouglasK , BerlinG , et al. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. British Journal of Dermatology2008;158(4):659-78.">Scarisbrick 2008</a>). </p> </section> <section id="CD009898-sec-0013"> <h3 class="title" id="CD009898-sec-0013">How the intervention might work</h3> <p>The mechanisms of action of ECP are not completely understood. It has been shown that the procedure induces apoptosis in mononuclear white blood cells (<a href="./references#CD009898-bbs2-0113" title="VossCY , FryTJ , CoppesMJ , BlajchmanMA . Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis. Transfusion Medicine Reviews2010;24(1):22-32.">Voss 2010</a>). However, only a small percentage of the peripheral mononuclear cells is treated and, therefore, an immunomodulatory effect of the apoptotic cells is hypothesised (<a href="./references#CD009898-bbs2-0047" title="HeshmatiF . Mechanisms of action of extracorporeal photochemotherapy. Transfusion and Apheresis Science2003;29(1):61-70.">Heshmati 2003</a>). One suspected mechanism is that apoptotic T‐cell fragments presented by dendritic cells induce an anti‐idiotypic T‐suppressor activity, or down‐regulate a pre‐existing T‐cell response, and in this way generate a tolerogenic response and modulate cytokine production (<a href="./references#CD009898-bbs2-0012" title="BladonJ , TaylorPC . The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization. Transplant International2006;19(4):319-24.">Bladon 2006</a>; <a href="./references#CD009898-bbs2-0069" title="LegitimoA , ConsoliniR , FailliA , FabianoS , BencivelliW , ScatenaF , et al. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype. Clinical and Experimental Immunology2007;148(3):564-72.">Legitimo 2007</a>; <a href="./references#CD009898-bbs2-0118" title="XiaCQ , CampbellKA , Clare-SalzlerMJ . Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Current Opinion in Organ Transplantation2009;14(4):338-43.">Xia 2009</a>). In summary, the postulated mechanisms involved include: reduced stimulation of effector T cells, deletion of effector T cells, induction of regulatory T cells, increase of anti‐inflammatory cytokines (i.e. tumour necrosis factor‐beta, interleukin‐10), and reduction of proinflammatory cytokines (interleukin‐1beta, interleukin‐6, and tumour necrosis factor‐alpha) (<a href="./references#CD009898-bbs2-0030" title="FimianiM , Di RenzoM , RubegniP . Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. British Journal of Dermatology2004;150(6):1055-60.">Fimiani 2004</a>). On the basis of this hypothesis, photopheresis seems to down‐regulate the T‐cell alloreactivity that plays the central role in the pathogenesis of GvHD after HSCT (<a href="./references#CD009898-bbs2-0066" title="LamioniA , ParisiF , IsacchiG , GiordaE , Di CesareS , LandolfoA , et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation2005;79(7):846-50.">Lamioni 2005</a>; <a href="./references#CD009898-bbs2-0072" title="MaedaA , SchwarzA , KernebeckK , GrossN , AraganeY , PerittD , et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. Journal of Immunology2005;174(10):5968-76.">Maeda 2005</a>). </p> </section> <section id="CD009898-sec-0014"> <h3 class="title" id="CD009898-sec-0014">Why it is important to do this review</h3> <p>cGvHD remains one of the major challenges for transplant‐related morbidity and mortality after stem cell transplantation in children and adolescents. All conventional therapies, including established first‐line therapy, have considerable adverse effects and probably increase the risk of infections and relapse of malignant disease. Therefore, it is essential to develop new therapeutic approaches for the selective immune control of cGvHD without generalised immunosuppression‐related complications (infections and pharmacological toxicity issues) (<a href="./references#CD009898-bbs2-0117" title="WolffD , SchleuningM , Von HarsdorfS , BacherU , GerbitzA , StadlerM , et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2011;17(1):1-17.">Wolff 2011</a>). ECP seems to be an effective immunomodulatory therapy with very mild, if any, adverse effects and, therefore, may be a promising alternative for improving morbidity and mortality in children with cGvHD. </p> <p>The aim of the second update of this systematic review, including its protocol (<a href="./references#CD009898-bbs2-0124" title="WeitzM , StrahmB , MeerpohlJJ , BasslerD . Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database of Systematic Reviews2012, Issue 6. Art. No: CD009898. [DOI: 10.1002/14651858.CD009898]">Weitz 2012</a>), its initial review (<a href="./references#CD009898-bbs2-0125" title="WeitzM , StrahmB , MeerpohlJJ , BasslerD . Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD009898. [DOI: 10.1002/14651858.CD009898.pub2]">Weitz 2014</a>) and its first update (<a href="./references#CD009898-bbs2-0126" title="WeitzM , StrahmB , MeerpohlJJ , SchmidtM , BasslerD . Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. The Cochrane database of systematic reviews2015;2015(12):Cd009898. [DOI: 10.1002/14651858.CD009898.pub3]">Weitz 2015</a>), was to identify new RCTs evaluating the efficacy and safety of ECP in children and adolescents with cGvHD. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009898-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009898-sec-0015"></div> <p>To evaluate the effectiveness and safety of ECP for the management of cGvHD in children and adolescents after haematopoietic stem cell transplantation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009898-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009898-sec-0016"></div> <section id="CD009898-sec-0017"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009898-sec-0018"> <h4 class="title">Types of studies</h4> <p>We intended to consider randomised controlled trials (RCTs) for this review if they assessed any clinical outcome as described in the <a href="#CD009898-sec-0021">Types of outcome measures</a> section. For medical reasons (e.g. we did not consider cGvHD a stable condition), we aimed to include only trials with a parallel group design. We excluded studies restricted to adults (≥ 18 years of age). For studies including both children and adults, we planned to include studies if children represented more than 50% of participants in the study. </p> </section> <section id="CD009898-sec-0019"> <h4 class="title">Types of participants</h4> <p>We planned to include children and adolescents under 18 years of age who underwent HSCT therapy with presence of cGvHD, independent of the underlying disease and donor source. We planned to consider all stages and grades of cGvHD, independent of the type of organ involvement. </p> </section> <section id="CD009898-sec-0020"> <h4 class="title">Types of interventions</h4> <p>For the purpose of this review, we considered systemic steroids with or without calcineurin inhibitors as standard treatment as first‐line therapy and considered all other treatment as second‐line therapy of cGvHD. </p> <p>The following comparisons for ECP for cGvHD after HSCT were conceivable:</p> <p> <ul id="CD009898-list-0001"> <li> <p>ECP versus standard treatment in children and adolescents with cGvHD as first‐line treatment. </p> </li> <li> <p>ECP plus standard treatment versus standard treatment alone in children and adolescents with cGvHD as first‐line treatment. </p> </li> <li> <p>ECP versus standard treatment in children and adolescents with steroid‐/calcineurin‐inhibitor‐refractory cGvHD (second‐line treatment). </p> </li> <li> <p>ECP plus standard treatment versus standard treatment alone in children and adolescents with steroid‐/calcineurin‐inhibitor‐refractory cGvHD (second‐line treatment). </p> </li> </ul> </p> <p>These comparisons constituted four separate groups, and we anticipated analysing them separately. </p> </section> <section id="CD009898-sec-0021"> <h4 class="title">Types of outcome measures</h4> <section id="CD009898-sec-0022"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009898-list-0002"> <li> <p>Response to ECP treatment (defined as either classical response rates (i.e. number of people in complete or partial remission) or percentage of achieved reduction in either NIH score (<a href="./references#CD009898-bbs2-0029" title="FilipovichAH , WeisdorfD , PavleticS , SocieG , WingardJR , LeeSJ , et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2005;11(12):945-56.">Filipovich 2005</a>; <a href="./references#CD009898-bbs2-0057" title="JagasiaMH , SavaniBN , StricklinG , EngelhardtB , KassimA , DixonS , et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biology of Blood and Marrow Transplantation2009;15(10):1288-95. [NCT01380535]">Jagasia 2009</a>; <a href="./references#CD009898-bbs2-0058" title="JagasiaMH , GreinixHT , AroraM , WilliamsKM , WolffD , CowenEW , et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2015;21(3):389-401.">Jagasia 2015</a>; <a href="./references#CD009898-bbs2-0095" title="SchoemansHM , LeeSJ , FerraraJL , WolffD , LevineJE , SchultzKR , et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology &amp; guidance for graft-versus-host disease assessment. Bone Marrow Transplantation2018;53(11):1401-15.">Schoemans 2018</a>), scales of Akpek and Lee (<a href="./references#CD009898-bbs2-0003" title="AkpekG , LeeSM , AndersV , VogelsangGB . A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2001;7(9):495-502.">Akpek 2001</a>; <a href="./references#CD009898-bbs2-0067" title="LeeSJ , VogelsangG , FlowersME . Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2003;9(4):215-33.">Lee 2003</a>), or steroid‐tapering under therapy with ECP (defined as number of people with at least 25% reduction in steroid dose). </p> </li> </ul> </p> </section> <section id="CD009898-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009898-list-0003"> <li> <p>Overall survival (defined as the time to death from any cause, starting at the day of HSCT). </p> </li> <li> <p>Failure‐free survival (defined as progression of GvHD, expressed as change in NIH score or intensification of treatment, or both). </p> </li> <li> <p>Adverse events.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Cost of intervention per month including length of hospital stay in days, number of outpatient attendances, direct medical resource use, direct medical costs, indirect medical resource use or costs and patient out‐of‐pocket expenses. </p> </li> </ul> </p> </section> </section> </section> <section id="CD009898-sec-0024"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009898-sec-0025"> <h4 class="title">Electronic searches</h4> <p>For the original review, we carried out an electronic search for the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 9, 2012), MEDLINE/PubMed (from 1945 to 12 September 2012) and Embase (Ovid) (from 1980 to 12 September 2012). The search strategies for the different electronic databases (using a combination of controlled vocabulary and text words) are displayed in the appendices (<a href="./appendices#CD009898-sec-0065">Appendix 1</a>; <a href="./appendices#CD009898-sec-0066">Appendix 2</a>; <a href="./appendices#CD009898-sec-0067">Appendix 3</a>). </p> <p>For the 2015 search update, we applied the same strategy without modifications to identify studies from the date of the last search to 23 September 2015. </p> <p>Due to the extended time period of more than five years between the first and the second update we decided to repeat the full search for the 2021 update in CENTRAL (Issue 1, 2021), MEDLINE/PubMed (from 1945 to 25 January 2021) and Embase database (<a href="https://www.embase.com" target="_blank">www.embase.com</a>) (from 1980 to 25 January 2021). We only modified the search strategies for the Embase search according to the use of the embase.com platform for the second update instead of the Ovid platform used previously (<a href="./appendices#CD009898-sec-0068">Appendix 4</a>). </p> </section> <section id="CD009898-sec-0026"> <h4 class="title">Searching other resources</h4> <section id="CD009898-sec-0027"> <h5 class="title">Conference proceedings:</h5> <p>For the original review, we also searched the conference proceedings mentioned below using the regular search with keyword terms ("extracorporeal"; "photopheresis"; "photochemotherapy"; "psoralen"; "graft‐versus‐host") on 12 September 2012. </p> <p>To cover conference proceedings from after the latest search date, for the 2015 and 2021 update, we re‐ran the searches without modifications on 29 September 2015 and 9 November 2020, respectively. Overall, these searches comprised the conference proceedings of the following societies and time spans: </p> <p> <ul id="CD009898-list-0004"> <li> <p>International Society for Paediatric Oncology (SIOP) (from 2007 to 2020);</p> </li> <li> <p>American Society of Clinical Oncology (ASCO): <i>Journal of Clinical Oncology</i> (1995 to 2020); </p> </li> <li> <p>American Society of Hematology (ASH): <i>Blood</i> (2001 to 2020); </p> </li> <li> <p>American Society for Transplantation and Cellular Therapy, formerly American Society of Blood and Marrow Transplantation: <i>Biology of Blood and Marrow Transplantation</i> (1990 to 2020) </p> </li> <li> <p>European Society for Blood and Marrow Transplantation, formerly European Group for Blood and Marrow Transplantation (EBMT): <i>Bone Marrow Transplantation</i> (2000 to 2020). </p> </li> </ul> </p> </section> <section id="CD009898-sec-0028"> <h5 class="title">Clinical trials registries:</h5> <p>In addition, for the initial review, we searched the following clinical trials registries for ongoing or recently completed trials, and for locating potential links to other related databases and resources for the initial review on 12 September 2012. </p> <p>For the 2015 update of this review, we repeated the search for clinical trials on 29 September 2015, and for the 2021 update, on 12 November 2020. </p> <p>We performed a regular search with keywords ("extracorporeal"; "photopheresis"; "photochemotherapy"; "psoralen"; "graft‐versus‐host") where applicable, applied no time restrictions, and did not limit the search to trials involving children. </p> <p>We carried out all searches within the following clinical trials registries:</p> <p> <ul id="CD009898-list-0005"> <li> <p>International Standard Randomized Controlled Trial Number (ISRCTN) registry (<a href="http://controlled-trials.com/" target="_blank">controlled-trials.com/</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>); </p> </li> <li> <p>Trials Central (<a href="http://www.trialscentral.org/" target="_blank">www.trialscentral.org/</a>) (for the previous review versions: via 'condition': 'graft vs host disease'; for the second update: via 'condition': 'Hematologic Diseases'); </p> </li> <li> <p>Internet Portal of the German Clinical Trials Register (DRKS) (<a href="http://www.drks.de/" target="_blank">www.drks.de/</a>); </p> </li> <li> <p>NCIC Clinical Trials Group (<a href="http://www.ctg.queensu.ca/" target="_blank">www.ctg.queensu.ca/</a>); </p> </li> <li> <p>National Cancer Institute (<a href="http://www.cancer.gov/" target="_blank">www.cancer.gov/</a>) (under heading 'childhood cancers' and 'cancers in childhood and adolescents' using the 'research' button in both the initial review (2014) and the first update (2015); searching with the keywords mentioned above in the 2021 update); </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (ANZCTR) (<a href="http://www.anzctr.org.au/trialSearch.aspx" target="_blank">www.anzctr.org.au/trialSearch.aspx</a>). </p> </li> </ul> </p> <p>Furthermore, for the 2021 review update we added a search in the following trials' registry: </p> <p> <ul id="CD009898-list-0006"> <li> <p>European Union (EU) Clinical Trials Register (<a href="https://www.clinicaltrialsregister.eu" target="_blank">www.clinicaltrialsregister.eu</a>). </p> </li> </ul> </p> </section> <section id="CD009898-sec-0029"> <h5 class="title">Further resources:</h5> <p>We reviewed the reference lists of relevant articles and review articles in order to identify additional studies. For the original review and its update we also contacted two selected experts in the field to request information on unpublished trials evaluating ECP in cGvHD following HSCT. </p> </section> <section id="CD009898-sec-0030"> <h5 class="title">Additional information regarding the searches:</h5> <p>We applied no language restrictions.</p> <p>In the initial review and its first update, we listed educational reviews, non‐randomised controlled studies, case reports and case series as 'excluded studies' (<a href="./appendices#CD009898-sec-0069">Appendix 5</a> and <a href="./appendices#CD009898-sec-0071">Appendix 6</a>, respectively). For this second update, we decided to update both the full search and the study selection process. Consequently, we removed all studies not meeting the inclusion criteria in the study selection process. </p> </section> </section> </section> <section id="CD009898-sec-0031"> <h3 class="title" id="CD009898-sec-0031">Data collection and analysis</h3> <section id="CD009898-sec-0032"> <h4 class="title">Selection of studies</h4> <p>The original review was undertaken by four review authors (MW, BS, FM, DB). One review author (MW) screened all titles and abstracts of the references identified by the search strategies for relevance. We only excluded citations that were clearly irrelevant at this stage. We considered citations as irrelevant that included only adults, were animal studies, did not describe cGvHD or used stem cell sources other than haematopoietic. Two review authors (MW, DB) independently screened the remaining titles, excluded all irrelevant publications and recorded details of the studies together with the reasons for exclusion. We resolved any disagreement on the eligibility of studies through discussion and consensus. We obtained full‐text versions of all potentially relevant papers. Two review authors (MW, DB) independently screened these manuscripts, identified potentially relevant studies and assessed eligibility of studies for inclusion. We resolved any disagreements on the eligibility of studies through discussion and consensus. For the 2015 update, an additional author (MS) screened titles, abstracts and potentially relevant studies. For the 2021 update, three additional authors (MZ, SB, KB) screened titles and abstracts (SB, KB) and potentially relevant studies (MZ, KB). </p> </section> <section id="CD009898-sec-0033"> <h4 class="title">Data extraction and management</h4> <p>We planned to extract data using a data extraction form developed by the review authors, and one of the review authors (MW) would transcribe the data into Review Manager 5.4.1 (previous versions in the initial review and its first update; <a href="./references#CD009898-bbs2-0091" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a> for the second update in 2021). Another review author (JM for the initial review and its first update, KB for the second update) was to verify all data entry for discrepancies. We planned to resolve any disagreements on data extraction and management issues through discussion and consensus, or if necessary through a third review author (DB or BS). We intended to request missing data from the original investigators. </p> <p>Two review authors (MW and JM for the original review and its first update, MZ and KB for this second update) would have completed the characteristics of included studies table. Study characteristics would have included place of publication, date of publication, population characteristics, setting, detailed nature of intervention, detailed nature of comparator and detailed nature of outcomes. A key purpose of these data was to define unexpected clinical heterogeneity in included studies independently of analysis of results. </p> <p>Two review authors (MW and JM for the original review and its first update, MZ and KB for this second update) intended to carefully record reasons why an included study did not contribute data on a particular outcome and to consider the possibility of selective reporting of results on particular outcomes. </p> </section> <section id="CD009898-sec-0034"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MW and DB for the initial review and its first update, MZ and KB for its second update) planned to assess independently each included study for risk of bias using the definitions for the different risk of bias items as stated in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009898-bbs2-0050" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley &amp; Sons, 2019:205-40. [Available from www.cochrane-handbook.org 2019]">Higgins 2019</a>): random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and any other potential threats to validity (<a href="./references#CD009898-bbs2-0050" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley &amp; Sons, 2019:205-40. [Available from www.cochrane-handbook.org 2019]">Higgins 2019</a>; <a href="./references#CD009898-bbs2-0064" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine2001;135(11):982-9.">Kjaergard 2001</a>; <a href="./references#CD009898-bbs2-0080" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet1998;352(9128):609-13.">Moher 1998</a>; <a href="./references#CD009898-bbs2-0097" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association1995;273(5):408-12.">Schulz 1995</a>). We also planned to assess the risk of bias for blinding of outcome assessors and incomplete outcome data separately for each outcome. We aimed to consider a trial as having a low risk of bias if we assessed all domains as adequate. We planned to consider a trial as having a high risk of bias if we assessed one or more domain as inadequate or unclear. We wanted to report the risk of bias table as part of the characteristics of included studies table, and present a risk of bias summary figure that would detail all the judgements made for all included studies in the review (<a href="./references#CD009898-bbs2-0050" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editors(s). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley &amp; Sons, 2019:205-40. [Available from www.cochrane-handbook.org 2019]">Higgins 2019</a>). For each included study, we planned to assess selective reporting bias by comparing the methods and results section of the individual studies. We intended to resolve any disagreements on the assessment of risk of bias through discussion and consensus, or if necessary through a third review author (JM or BS) and to explore the impact of the level of bias through undertaking sensitivity analyses (see <a href="#CD009898-sec-0042">Sensitivity analysis</a>). </p> </section> <section id="CD009898-sec-0035"> <h4 class="title">Measures of treatment effect</h4> <p>We planned to analyse extracted data using Review Manager 5 (<a href="./references#CD009898-bbs2-0091" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>). </p> <p>We planned to extract hazard ratios (HR) with their 95% confidence intervals (CI) for time‐to‐event outcomes, such as mortality. If HRs were not provided, we intended to use the indirect estimation methods described in <a href="./references#CD009898-bbs2-0085" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815-34.">Parmar 1998</a> and <a href="./references#CD009898-bbs2-0116" title="WilliamsonPR , SmithCT , HuttonJL , MarsonAG . Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine2002;21(22):3337-51.">Williamson 2002</a> to calculate them. As an alternative, we intended to use the proportions of participants with the respective outcomes measured at certain time points to calculate risk ratios (RR). </p> <p>We planned to express results for binary outcomes as RRs with 95% CIs as measures of uncertainty. For continuous outcomes, we planned to express the results as mean differences (MD), with 95% CIs as measures of uncertainty. </p> </section> <section id="CD009898-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>Since, for medical reasons, we only aimed to include parallel group randomised trials, unit of analysis issues related to cross‐over and cluster randomised trials were not relevant for this systematic review. In the context of ECP, 'body‐part randomisation' and 'body part analyses' did not make sense, so related issues do not need to be discussed here. In cases of parallel group designs with three or more treatment groups, we planned to divide the control group into several parts, so that the total number added up to the original size of the group. </p> </section> <section id="CD009898-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>We planned to contact original investigators for missing data regarding study selection, data extraction and risk of bias assessment. To optimise the strategy for dealing with missing data, we intended to conduct an intention‐to‐treat analysis, which would have included all participants who did not receive the assigned intervention according to the protocol, as well as those who were lost to follow‐up. If unsuccessful, we wanted to address the potential impact of missing data on the findings of the review in the Discussion section. </p> </section> <section id="CD009898-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess statistical heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD009898-bbs2-0048" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>; <a href="./references#CD009898-bbs2-0049" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). This measure describes the percentage of total variation across studies that is caused by heterogeneity rather than by chance (<a href="./references#CD009898-bbs2-0049" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). The values of I<sup>2</sup> lie between 0% and 100%. We planned to use a simplified categorisation of heterogeneity with the following categories: low (I<sup>2</sup> less than 30%), moderate (I<sup>2</sup> between 30% and 60%) and high (I<sup>2</sup> more than 60%) (<a href="./references#CD009898-bbs2-0022" title="DeeksJ , HigginsJ , AltmanD . Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Deeks 2011</a>). </p> <p>If moderate or high heterogeneity had been detected, we intended to explore clinical heterogeneity by examining differences between groups as detailed below (<a href="http://ovidsp.tx.ovid.com/sp-3.3.1a/ovidweb.cgi?&amp;S=CEFJFPGPCJDDOIILNCCLJHJCLIPKAA00&amp;Link+Set=S.sh.41%7c4%7csl_50#172" target="_blank">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> <section id="CD009898-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>We minimised the likelihood of publication bias by using a comprehensive search strategy without language restrictions, and we also searched trial registries. In addition to the evaluation of reporting bias, as described in the <a href="#CD009898-sec-0034">Assessment of risk of bias in included studies</a> section, we planned to assess reporting bias by constructing a funnel plot where a sufficient number of studies had been identified (i.e. at least 10 studies included in a meta‐analysis). If there were fewer studies, the power of these tests would be too low to distinguish chance from real asymmetry (<a href="./references#CD009898-bbs2-0102" title="SterneJA , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Sterne 2011</a>). </p> </section> <section id="CD009898-sec-0040"> <h4 class="title">Data synthesis</h4> <p>For future updates, we will conduct meta‐analyses of pooled data from all contributing studies using Review Manager 5 (<a href="./references#CD009898-bbs2-0091" title="Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration, 2020.">RevMan 2020</a>). We intended to use a fixed‐effect model as primary analysis. If we had found high clinical, methodological or statistical heterogeneity (I<sup>2</sup> more than 50%), we would, as a secondary analysis, have used a random‐effects model and reported results from both models. We planned to summarise studies in cases where pooling of results was not possible. </p> </section> <section id="CD009898-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to assess clinical heterogeneity by examining differences due to:</p> <p> <ul id="CD009898-list-0007"> <li> <p>underlying disease;</p> </li> <li> <p>type of haematopoietic stem cell source;</p> </li> <li> <p>age of children at HSCT;</p> </li> <li> <p>age at start of ECP;</p> </li> <li> <p>type of conditioning regimen;</p> </li> <li> <p>type of GvHD prophylaxis regimen; and</p> </li> <li> <p>degree of human leukocyte antigen (HLA) compatibility (matched sibling donor versus matched unrelated donor versus mismatched unrelated donor). </p> </li> </ul> </p> </section> <section id="CD009898-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to investigate the robustness of our results through a sensitivity analysis on the basis of risk of bias of the included studies by defining the following groups: </p> <p> <ul id="CD009898-list-0008"> <li> <p>low risk of bias (adequate sequence generation and allocation concealment; successful blinding of all participants, care providers and outcome assessors; incomplete outcome data for less than 20% of participants; no selective reporting or other sources of bias); </p> </li> <li> <p>high risk of bias (no adequate sequence generation and allocation concealment; no adequate blinding of all participants, care providers and outcome assessors; incomplete outcome data for more than 20% of participants; selective reporting or other sources of bias); </p> </li> <li> <p>unclear risk of bias (rating of unclear risk of bias in at least one of these seven categories). </p> </li> </ul> </p> <p>We intended to perform sensitivity analyses for each risk of bias item separately.</p> </section> <section id="CD009898-sec-0043"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We planned to prepare summary of findings tables based on the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD009898-bbs2-0051" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>) and using GRADEpro software (<a href="./references#CD009898-bbs2-0042" title="GRADEpro GDT. Version accessed 18 March 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEproGDT</a>). For each comparison we would have presented the following outcomes: response, overall survival, failure‐free survival, adverse events, quality of life and costs of intervention per month. Two review authors would have independently assessed the certainty of the evidence (i.e. very low, low, moderate or high certainty) for each outcome according to the GRADE approach, which takes into account study limitations (risk of bias), inconsistency, indirectness, imprecision and publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009898-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009898-sec-0044"></div> <section id="CD009898-sec-0045"> <h3 class="title">Description of studies</h3> <p>We found no RCTs meeting the inclusion criteria for the original version of the review, its first update in 2015 or this second update in 2021 (<a href="#CD009898-fig-0001">Figure 1</a>; <a href="#CD009898-fig-0002">Figure 2</a>; <a href="#CD009898-fig-0003">Figure 3</a>) (see: <a href="./references#CD009898-sec-0109" title="">Characteristics of excluded studies</a> table). </p> <div class="figure" id="CD009898-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Identification of potentially eligible reports for the original review in 2014." data-id="CD009898-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Identification of potentially eligible reports for the original review in 2014.</p> </div> </div> </div> <div class="figure" id="CD009898-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Identification of potentially eligible reports for the first review update in 2015." data-id="CD009898-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Identification of potentially eligible reports for the first review update in 2015.</p> </div> </div> </div> <div class="figure" id="CD009898-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Identification of potentially eligible reports for the second review update in 2021." data-id="CD009898-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Identification of potentially eligible reports for the second review update in 2021.</p> </div> </div> </div> <section id="CD009898-sec-0046"> <h4 class="title">Results of the search</h4> <p>The latest full search was carried out in the electronic literature databases on 25 January 2021, in the clinical trials registries on 12 November 2020, and in the conference proceedings on 9 November 2020. </p> <p>These searches yielded 383 records including 46 duplicates or quadruplets in CENTRAL, MEDLINE, Embase, conference proceedings and clinical trials registries. <a href="#CD009898-fig-0003">Figure 3</a> depicts the result of the latest search strategy. After title and abstract screening of 337 unique references, we retrieved one article for full text review. This RCT was already mentioned in the previous versions of this review (<a href="./references#CD009898-bbs2-0001" title="FlowersME , ApperleyJF , vanBesienK , ElmaagacliA , GriggA , ReddyV , et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood2008;112(7):2667-74. [NCT00054613]">Flowers 2008</a>; see <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009898.pub2/full#CD009898-sec3-0021" target="_blank">Excluded studies</a>), but was excluded due to paediatric participants presenting less than 50% of the total study population. </p> </section> <section id="CD009898-sec-0047"> <h4 class="title">Included studies</h4> <p>We found no RCTs meeting the inclusion criteria for this 2021 review update.</p> </section> <section id="CD009898-sec-0048"> <h4 class="title">Excluded studies</h4> <p>For this 2021 review update, we excluded additional data from one RCT, which was already mentioned in the previous review versions. </p> <p>See <a href="./references#CD009898-sec-0109" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD009898-sec-0049"> <h3 class="title">Risk of bias in included studies</h3> <p>We found no studies meeting the inclusion criteria for the original version of this review, its first update in 2015 or this second update in 2021. Therefore, the assessment of risk of bias was not applicable. </p> </section> <section id="CD009898-sec-0050"> <h3 class="title" id="CD009898-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD009898-tbl-0001"><b>Summary of findings 1</b> Summary of findings</a> </p> <p>We found no studies meeting the inclusion criteria for the initial review, the first update in 2015 or this second update in 2021 (<a href="./full#CD009898-tbl-0001">summary of findings Table 1</a>). For that reason, the effectiveness and safety of ECP therapy in children and adolescents with cGvHD following HSCT remain unclear. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009898-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009898-sec-0051"></div> <section id="CD009898-sec-0052"> <h3 class="title" id="CD009898-sec-0052">Summary of main results</h3> <section id="CD009898-sec-0053"> <h4 class="title">General findings</h4> <p>Chronic GvHD represents one of the major challenges for transplant‐related morbidity and mortality after HSCT in children and adolescents. In these patients, ECP is an alternative second‐ or third‐line treatment option. However, as in the previous review versions, this second update in 2021 identified no RCTs involving a study population of at least 50% paediatric participants aged ≤ 18 years. In the absence of reliable data from RCTs, this systematic review is still not able to ascertain if ECP treatment in children and adolescents with cGvHD after HSCT is an effective and safe option. </p> </section> <section id="CD009898-sec-0054"> <h4 class="title">Paediatric studies evaluating ECP in cGvHD after HSCT</h4> <p>The available body of evidence on efficacy and safety of ECP in the paediatric population with cGvHD following HSCT suggests a benefit of ECP treatment in these patients. However, this evidence is limited to case reports, case series and mainly retrospective observational studies. As a consequence of methodological limitations, such as the non‐randomised study designs as well as inhomogeneous disease and response definitions, the results of these studies are difficult to compare and to transfer into clinical practice. </p> <p>There was one earlier prospective trial designed as phase 2 study, which intended to examine the efficacy and safety of ECP added in adult and paediatric participants with cGvHD aged ≥ 4 years, weighting ≥ 30 kg, and not responding to steroids and ciclosporin A within 14 days. However, despite the enrolment of 25 participants in the study, the results have not yet been published (<a href="./references#CD009898-bbs2-0083" title="NCT00048789. Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease. clinicaltrials.gov/ct2/show/NCT00048789 (first received 8 November 2002).">NCT00048789</a>). </p> </section> <section id="CD009898-sec-0055"> <h4 class="title">RCTs evaluating ECP in cGvHD after HSCT</h4> <p>During the initial review in 2014, we identified only one RCT examining the efficacy of ECP in cGvHD that aimed to include children weighing at least 40 kg among the participants (<a href="./references#CD009898-bbs2-0001" title="FlowersME , ApperleyJF , vanBesienK , ElmaagacliA , GriggA , ReddyV , et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood2008;112(7):2667-74. [NCT00054613]">Flowers 2008</a>). This study finally enrolled mainly adults (greater than 50%; median age of the ECP and control arm 41 years (range 16 to 67) and 43 years (range 13 to 67), respectively). This randomised controlled, single‐blinded, multicentre trial investigated the effect of ECP as second‐line therapy for skin manifestation of cGvHD in people with failed corticosteroid treatment following HSCT. People were eligible in case of: corticosteroid refractoriness, defined as a lack of response or disease progression after administration of at least 1 mg/kg of methylprednisolone equivalent, corticosteroid‐dependency after more than 10 mg of methylprednisolone equivalent to control skin manifestation, and corticosteroid intolerance due to intolerable adverse effects. Steroids had to be applied in a stable dose for at least two weeks prior to randomisation and had to be maintained on the same dose level for the first six study weeks (with the exception of reduction due to adverse effects). Immunosuppressants such as tacrolimus, mycophenolate and ciclosporin A were accepted as concomitant medication if they had been introduced at least four weeks before randomisation. Discontinuation of these agents during the study period was only permitted for safety reasons. The primary objective of the study was the median percentage change of total skin score (TSS) at week 12 compared with the pretreatment value. Secondary objectives included: the proportion of participants with at least 25% improvement in TSS, 50% or greater reduction in daily steroid dose compared with the baseline dose, or improvement of at least 25% in TSS in conjunction with steroid‐sparing at weeks 12 and 24. Skin assessments were performed on alternate weeks up to study week 12 and afterwards on alternate weeks up to study week 24. Participants were randomised with a block scheme in a 1:1 ratio to the conventional therapy arm (n = 49) or to the conventional therapy arm combined with ECP (n = 50). Conventional therapy consisted of corticosteroids and other immunosuppressive agents in refractory participants. ECP was administered three times during week one, and then twice weekly on consecutive days during weeks two to 12. Responding participants could continue ECP treatment until week 24 following the schedule of two treatments every week. Ten participants (four in the study group, six in the control group) withdrew consent prior to study week 12. Four participants died due to multiple organ failure, cardiac failure and infection. The changes in TSS from baseline until week 12 between the ECP group (‐14.5%) and the control group (‐8.5%) were not statistically different (P = 0.48; 95% confidence interval (CI) not reported). However, ECP‐treated participants had a 50% or greater reduction in the total daily dose of corticosteroids. At week 12, the percentage of participants experiencing both a 50% or greater reduction in daily corticosteroid dose and a 25% or greater improvement in the TSS was higher in the ECP group (8%) than the control group (0%) (P = 0.04; 95% CI not reported). Regarding TSS, 40% of the participants in the ECP group had a complete or partial skin response compared with 10% in the control group (P = 0.002; 95% CI not reported). </p> <p>The aforementioned trial was continued as cross‐over randomised open‐label ECP study (<a href="./references#CD009898-bbs2-0044" title="GreinixHT , vanBesienK , ElmaagacliAH , HillenU , GriggA , KnoblerR , et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis - results of a crossover randomized study. Biology of Blood and Marrow Transplantation2011;17(12):1775-82.">Greinix 2011</a>). In total, 29 participants were enrolled who had initially been randomised to the conventional study arm and presented with progression of cutaneous cGvHD, TSS improvement &lt; 15% or steroid dose reduction ≤ 25% at the end of the previous study period. Of these, 25 participants completed the 24‐week ECP course. The prolonged duration of ECP resulted in an improvement of cutaneous and extracutaneous cGvHD, suggesting the need for prolonged ECP treatment in cGvHD to achieve sufficient treatment effects (<a href="./references#CD009898-bbs2-0044" title="GreinixHT , vanBesienK , ElmaagacliAH , HillenU , GriggA , KnoblerR , et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis - results of a crossover randomized study. Biology of Blood and Marrow Transplantation2011;17(12):1775-82.">Greinix 2011</a>). </p> <p>During the second review update in 2021, we found a further RCT, designed as a pilot phase 1 study and evaluating ECP as first‐line therapy in adults with HSCT‐related cGvHD (<a href="./references#CD009898-bbs2-0059" title="JagasiaM , ScheidC , SociéG , AyukFA , TischerJ , DonatoML , et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Advances2019;3(14):2218-29.">Jagasia 2019</a>). This multicentre RCT used the revised 2014 NIH consensus criteria for diagnosis and response assessment of cGvHD (<a href="./references#CD009898-bbs2-0058" title="JagasiaMH , GreinixHT , AroraM , WilliamsKM , WolffD , CowenEW , et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation2015;21(3):389-401.">Jagasia 2015</a>; <a href="./references#CD009898-bbs2-0068" title="LeeSJ , WolffD , KitkoC , KorethJ , InamotoY , JagasiaM , et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation2015;21(6):984-99.">Lee 2015</a>). Overall, 60 participants with new‐onset moderate or severe cGvHD (≤ 3 years from HSCT) participated in the study and were randomised 1:1 either into the experimental (standard therapy and ECP; n = 29) or control arm (standard therapy alone; n = 31). The standard therapy consisted of corticosteroids (with a prednisone (or equivalent) starting dose of 1 mg/kg per day, which was tapered per protocol by week 8) and a calcineurin inhibitor (ciclosporin A or tacrolimus, with drug‐monitoring according to centre‐specific therapeutic blood levels). In the experimental group, ECP was carried out three times during the first week, twice per week until week 10, followed by two treatments biweekly until week 18 and two treatments four‐weekly until week 26. The outcome parameters comprised efficacy endpoint(s) at week 28, safety evaluation throughout the trial and long‐term follow‐up endpoint(s) after two years. The primary efficacy endpoint was defined as overall response rate (ORR) considering either complete or partial response with reference to the 2015 NIH criteria (<a href="./references#CD009898-bbs2-0068" title="LeeSJ , WolffD , KitkoC , KorethJ , InamotoY , JagasiaM , et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation2015;21(6):984-99.">Lee 2015</a>). TSS change, cGvHD, cumulative steroid dose and quality of life were considered as secondary efficacy endpoints. The primary and secondary long‐term follow‐up endpoint was defined as overall and failure‐free survival, respectively. Most of the efficacy parameters were assessed bi‐ or four‐weekly until week 28, long‐term follow‐up was evaluated only in participants completing the 28‐week study period. Finally, due to missing baseline measurements, the intention‐to‐treat population comprised 53/60 individuals, including 29 in the experimental and 24 in the control arm. Of these, 20/29 versus 13/24 completed the 28‐week study‐period, and 15/29 versus 11/24 the two‐year‐follow‐up. At baseline assessment, 12/29 (41.1%) participants in the ECP group and 13/24 (54.2%) in the control arm were diagnosed with severe cGvHD, while progressive cGvHD onset was indicated for 6/29 (20.7%) and 1/24 (4.2%). For both study arms, organ involvement was as following: skin 15/29 (51.7%) versus 12/24 (50.0%); liver 4/29 (13.8%) versus 1/24 (4.2%); gastrointestinal tract 7/29 (24.1%) versus 3/29 (12.5%); and other organs 5/29 (17.2%) versus 0/24. The ORR estimated by blinded assessors at week 28 was 74.1% (95% CI: 53.7 to 88.9) in the ECP group and 60.9% (95% CI: 38.5 to 80.3) in the control arm. The investigator‐assessed ORR estimated at this time point was 56.0% (95% CI: 34.9 to 75.6) in the ECP and 66.7% (95% CI: 43.0 to 85.4) in the control group. Both groups presented with a decline in TSS from baseline to week 28 (experimental group versus control group: ‐22% ± 44% versus ‐34% ± 53%; P = 0.549, for blinded assessment; and ‐27% ± 29% versus ‐37% ± 43%; P = 0.856, for non‐blinded, investigator assessment). In both arms, the mean cumulative steroid dose at week 28 was similar. In contrast to participants additionally treated with ECP who did not show any quality of life changes over time, people treated with standard therapy alone indicated a decline in quality of life in several domains. In the entire study sample (n = 60), 17 participants accounted for 35 treatment‐related serious adverse events, including 8/27 (27.6%) participants in the ECP arm and 9/31 (29%) in the control arm. These adverse events led to the exclusion of six participants from each arm. Four participants died, all assigned to the ECP arm; however, death was not considered to be associated with ECP. Failure‐free survival was reported for 19/32 participants entering the two‐year follow‐up; the median failure‐free survival time was 12.5 months (95% CI: 4.8 to 22.4) in the ECP group and 7.8 months (95% CI: 1.8 to 19.5) in the control arm. </p> <p>In summary, these trials assumed beneficial effects of ECP in adults with aGvHD following HSCT. Although these two RCTs were well‐designed, the results should be interpreted with caution due to the small number of individuals included in the trials and the high number of withdrawals throughout the study periods in both studies. Moreover, neither study was able to show a clearly superior treatment effect of ECP when added to first‐line therapy in cGvHD or applied as second‐line therapy for people with inadequate response to first‐line therapy (<a href="./references#CD009898-bbs2-0001" title="FlowersME , ApperleyJF , vanBesienK , ElmaagacliA , GriggA , ReddyV , et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood2008;112(7):2667-74. [NCT00054613]">Flowers 2008</a>; <a href="./references#CD009898-bbs2-0059" title="JagasiaM , ScheidC , SociéG , AyukFA , TischerJ , DonatoML , et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Advances2019;3(14):2218-29.">Jagasia 2019</a>). However, these studies could serve as a basis for future trials which may answer the question about the utility of ECP in the treatment of people with cGvHD more precisely. </p> </section> </section> <section id="CD009898-sec-0056"> <h3 class="title" id="CD009898-sec-0056">Overall completeness and applicability of evidence</h3> <p>The available paediatric studies were not designed as RCTs and provided only low quality evidence for the efficacy of ECP in children with cGvHD after HSCT. Hence, they should not be used to establish recommendations in children and adolescents after HSCT. </p> <p>The presented adult RCTs showed several beneficial effects when ECP was either implemented as second‐line therapy or added to first‐line therapy (<a href="./references#CD009898-bbs2-0001" title="FlowersME , ApperleyJF , vanBesienK , ElmaagacliA , GriggA , ReddyV , et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood2008;112(7):2667-74. [NCT00054613]">Flowers 2008</a>; <a href="./references#CD009898-bbs2-0044" title="GreinixHT , vanBesienK , ElmaagacliAH , HillenU , GriggA , KnoblerR , et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis - results of a crossover randomized study. Biology of Blood and Marrow Transplantation2011;17(12):1775-82.">Greinix 2011</a>; <a href="./references#CD009898-bbs2-0059" title="JagasiaM , ScheidC , SociéG , AyukFA , TischerJ , DonatoML , et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Advances2019;3(14):2218-29.">Jagasia 2019</a>). However, until these results are confirmed by larger studies covering longer follow‐up periods, the real benefit of ECP as first‐ or second‐line therapy in people with cGvHD after HSCT remains undetermined. </p> <p>Furthermore, insights gained from data of RCTs performed in the adult population are difficult to transfer into the paediatric population due to varying indications for HSCT, different comorbidities, long‐life expectancy, discrepancies in pharmacokinetics and the critical role of safety issues in children and adolescents, amongst others. </p> </section> <section id="CD009898-sec-0057"> <h3 class="title" id="CD009898-sec-0057">Quality of the evidence</h3> <p>We did not include any RCTs in this review, so were unable to assess the quality of the evidence.  </p> </section> <section id="CD009898-sec-0058"> <h3 class="title" id="CD009898-sec-0058">Potential biases in the review process</h3> <p>For this second update in 2021, we chose to perform an updated full search. This latest and thorough search yielded significantly more records than the previous searches performed for the initial review and its first update (<a href="./references#CD009898-bbs2-0125" title="WeitzM , StrahmB , MeerpohlJJ , BasslerD . Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD009898. [DOI: 10.1002/14651858.CD009898.pub2]">Weitz 2014</a>; <a href="./references#CD009898-bbs2-0126" title="WeitzM , StrahmB , MeerpohlJJ , SchmidtM , BasslerD . Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. The Cochrane database of systematic reviews2015;2015(12):Cd009898. [DOI: 10.1002/14651858.CD009898.pub3]">Weitz 2015</a>). This may be attributed to several technical changes within the electronic literature databases, especially in MEDLINE (PubMed) in May 2020. Conversely, based on a less inclusive study selection process with strict elimination of studies not meeting the inclusion criteria, the number of records retrieved for full text assessment was significantly lower than in the previous review versions. </p> <p>In order to detect all available information, we used a comprehensive search strategy that combined automated and manual search techniques. Nevertheless, missing information could not be completely ruled out. </p> </section> <section id="CD009898-sec-0059"> <h3 class="title" id="CD009898-sec-0059">Agreements and disagreements with other studies or reviews</h3> <p>Given the heterogeneous organ manifestations in cGvHD and the limited evidence for most treatment options, there is still no standardised treatment for children and adults with cGvHD following HSCT. This applies especially for those people who failed first‐line therapy with steroids and concomitant immunosuppressants. Several clinical practice guidelines on the treatment of adult and paediatric cGvHD advise consideration of ECP as secondary treatment for cGvHD (<a href="./references#CD009898-bbs2-0024" title="DignanFL , AmroliaP , ClarkA , CornishJ , JacksonG , MahendraP , et al. Diagnosis and management of chronic graft-versus-host disease. British Journal of Haematology2012;158(1):46-61.">Dignan 2012</a>; <a href="./references#CD009898-bbs2-0033" title="FlowersME , MartinPJ . How we treat chronic graft-versus-host disease. Blood2015;125(4):606-15.">Flowers 2015</a>; <a href="./references#CD009898-bbs2-0117" title="WolffD , SchleuningM , Von HarsdorfS , BacherU , GerbitzA , StadlerM , et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation2011;17(1):1-17.">Wolff 2011</a>). These guidelines were based on the limited number of RCTs and mainly resulted from evidence provided by non‐RCTs, including literature reviews and expert opinions, suggesting possible benefits from ECP treatment. Within this context, the Haemato‐oncology subgroup of the British Committee for Standards in Haematology and the British Society for Bone Marrow Transplantation recommended consideration of ECP as second‐line treatment for people with cGvHD with skin, oral or liver involvement (graded as a 1B recommendation) and as third‐line treatment in other organ manifestations (graded as a 2C recommendation) (<a href="./references#CD009898-bbs2-0024" title="DignanFL , AmroliaP , ClarkA , CornishJ , JacksonG , MahendraP , et al. Diagnosis and management of chronic graft-versus-host disease. British Journal of Haematology2012;158(1):46-61.">Dignan 2012</a>). Overall, the American Association for Apheresis graded the use of ECP in people with cGvHD following HSCT as a 1B recommendation (<a href="./references#CD009898-bbs2-0084" title="PadmanabhanA , Connelly-SmithL , AquiN , BalogunRA , KlingelR , MeyerE , et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue. Journal of Clinical Apheresis2019;34(3):171-354.">Padmanabhan 2019</a>). </p> <p>Previous systematic reviews and meta‐analyses evaluating ECP in cGvHD were based on different study selection criteria, did not focus particularly on the paediatric population and addressed different research questions (<a href="./references#CD009898-bbs2-0002" title="Abu-DalleI , ReljicT , NishihoriT , AntarA , BazarbachiA , DjulbegovicB , et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biology of Blood and Marrow Transplantation2014;20(11):1677-86.">Abu‐Dalle 2014</a>; <a href="./references#CD009898-bbs2-0073" title="MalikMI , LitzowM , HoganW , PatnaikM , MuradMH , ProkopLJ , et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis. Blood Research2014;49(2):100-6.">Malik 2014</a>; <a href="./references#CD009898-bbs2-0119" title="YalnizFF , MuradMH , LeeSJ , PavleticSZ , KheraN , ShahND , et al. Steroid refractory chronic graft-versus-host disease: cost-effectiveness analysis. Biology of Blood and Marrow Transplantation2018;24(9):1920-7.">Yalniz 2018</a>). However, these also emphasised the critical issues of the available body of evidence and the urgent need for high‐quality studies, notably RCTs, in order to better define the role of ECP in cGvHD. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009898-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/urn:x-wiley:14651858:media:CD009898:CD009898-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Identification of potentially eligible reports for the original review in 2014." data-id="CD009898-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_t/tCD009898-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Identification of potentially eligible reports for the original review in 2014.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009898-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/urn:x-wiley:14651858:media:CD009898:CD009898-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Identification of potentially eligible reports for the first review update in 2015." data-id="CD009898-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_t/tCD009898-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Identification of potentially eligible reports for the first review update in 2015.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009898-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/urn:x-wiley:14651858:media:CD009898:CD009898-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Identification of potentially eligible reports for the second review update in 2021." data-id="CD009898-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_t/tCD009898-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Identification of potentially eligible reports for the second review update in 2021.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/media/CDSR/CD009898/image_n/nCD009898-FIG-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009898-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Extracorporeal photopheresis (ECP) compared with alternative treatment for chronic graft‐versus‐host disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and adolescents with chronic graft‐versus‐host disease after haematopoietic stem cell transplantation </p> <p><b>Settings:</b> paediatric hospitals worldwide </p> <p><b>Intervention:</b> ECP alone or in combination with standard treatment </p> <p><b>Comparison:</b> alternative treatment alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk without ECP</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with ECP</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Response</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure‐free survival</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cost of intervention per month</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 participants (0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not applicable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>*The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% confidence interval).<br/><b>CI:</b> Confidence interval; <b>RCT</b>s: randomised controlled trials. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009898.pub4/full#CD009898-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009898.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009898-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009898-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009898-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD009898-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD009898-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009898-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009898-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009898\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009898\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009898\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009898\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009898\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PSzzz2OT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009898.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009898.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009898.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009898.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009898.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718821530"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009898.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718821534"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009898.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd9b47ff0935f',t:'MTc0MDcxODgyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 